Cost-effectiveness of a pentavalent rotavirus vaccine in Japan

References

• Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-13
   PubMedGoogle Scholar
• Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002;21:221-7
   PubMed Web of Science ®Google Scholar
• Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008;122:1235-43
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:136-41
   PubMed Web of Science ®Google Scholar
• Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics 2002;109:259-61
   PubMed Web of Science ®Google Scholar
• Mast TC, Chen PY, Lu KC, et al. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005–2006. Vaccine 2010;28:3008-13
   PubMed Web of Science ®Google Scholar
• Mast TC, Walter EB, Bulotsky M, et al. Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J 2010;29:e19-e25
   PubMedGoogle Scholar
• Mast TC, DeMuro-Mercon C, Kelly CM, et al. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009;9:11
   PubMed Web of Science ®Google Scholar
• Brisson M, Senecal M, Drolet M, et al. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J 2010;29:73-5
   PubMed Web of Science ®Google Scholar
• Senecal M, Brisson M, Lebel MH, et al. Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): a prospective community-based study. Can J Infect Dis Med Microbiol 2008;19:397-404
   PubMed Web of Science ®Google Scholar
• Nakagomi T, Nakagomi O, Takahashi Y, et al. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005;192(1 Suppl):S106-10
   Google Scholar
• Yokoo M, Arisawa K, Nakagomi O. Estimation of annual incidence, age-specific incidence rate, and cumulative risk of rotavirus gastroenteritis among children in Japan. Jpn J Infect Dis 2004;57:166-71
   Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33
   PubMed Web of Science ®Google Scholar
• Vesikari T, Itzler R, Matson DO, et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 2007;11(2 Suppl):S29-S35
   Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22
   PubMed Web of Science ®Google Scholar
• Wu CL, Yang YC, Huang LM, et al. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009;27:1492-9
   Google Scholar
• Itzler RF, Chen PY, Lac C, et al. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children </=5 years of age in Taiwan. J Med Econ 2011;14:748-58
   PubMedGoogle Scholar
• Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan. Jpn J Infect Dis 2011;64:277-83
   PubMed Web of Science ®Google Scholar
• Lorgelly PK, Joshi D, Iturriza GM, et al. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom. Epidemiol Infect 2008;136:44-55
   PubMed Web of Science ®Google Scholar
• Newall AT, Beutels P, Macartney K, et al. The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 2007;25:8851-60
   PubMed Web of Science ®Google Scholar
• Rheingans RD, Constenla D, Antil L, et al. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007;21:205-16
   PubMed Web of Science ®Google Scholar
• Widdowson MA, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007;119:684-97
   PubMed Web of Science ®Google Scholar
• Goossens LM, Standaert B, Hartwig N, et al. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine 2008;26:1118-27
   PubMed Web of Science ®Google Scholar
• Melliez H, Levybruhl D, Boelle PY, et al. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 2008;26:706-15
   PubMed Web of Science ®Google Scholar
• Ho AM, Nelson EA, Walker DG. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective. Arch Dis Child 2008;93:52-8
   Google Scholar
• Milne RJ, Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health 2009;12:888-98
   PubMed Web of Science ®Google Scholar
• Jit M, Bilcke J, Mangen MJ, et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2009;27:6121-8
   PubMed Web of Science ®Google Scholar
• Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58:1-25
   PubMedGoogle Scholar
• Bernaola IE, Gimenez SF, Baca CM, et al. [Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]. An Pediatr (Barc) 2009;70:72-82
   Google Scholar
• Nohynek H, Salo H, Renko M, et al. Finland introduces rotavirus vaccine into the national vaccination programme in September 2009. Euro Surveill 2009;14:19322
   PubMedGoogle Scholar
• Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011;30:S25-9
   PubMed Web of Science ®Google Scholar
• Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010;28:7507-13
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus Vaccines WHO Position Paper – January 2013. Wkly Epidemiol Rec 2013;88:49-64
   PubMedGoogle Scholar
• Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the “vaccine gap”? Vaccine 2012;30:4752-6
   PubMed Web of Science ®Google Scholar
• Health Sciences Council IDS-CVC. Report of the Vaccine Evaluation Sub-committee. 2011. Tokyo, Japan: The Ministry of Health Labor and Welfare
   Google Scholar
• Kamiya H, Nakano T, Inoue M, et al. A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirus. J Infect Dis 2009;200(Suppl 1):S140-6
   Google Scholar
• Matson DO, Staat MA, Azimi P, et al. Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods. J Paediatr Child Health 2012;48:698-704
   Google Scholar
• Nelson EA, Tam JS, Bresee JS, et al. Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis 2005;192(Suppl 1):S71-9
   PubMedGoogle Scholar
• Glass RI, Bresee JS, Parashar UD, et al. First rotavirus vaccine licensed: is there really a need? Acta Paediatr Suppl 1999;88:2-8
   PubMedGoogle Scholar
• Martin A, Cottrell S, Standaert B. Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK. J Med Econ 2008;11:471-84
   PubMedGoogle Scholar
• Suarez-Almazor ME, Conner-Spady B, Kendall CJ, et al. Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making 2001;21:113-21
   PubMed Web of Science ®Google Scholar
• Muhlbacher AC, Juhnke C. Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy 2013;11:163-80
   PubMedGoogle Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Calva JJ, Guerrero L, et al. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J 1993;12:54-61
   PubMed Web of Science ®Google Scholar
• Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-effectivness in health and medicine. New York, NY: Oxford University Press, 1996
   Google Scholar
• Statistics Bureau, Portal Site of Official Statistics of Japan: Subgroup Index for Japan 2011. 2013. Tokyo, Japan: Ministry of Internal Affairs and Communications
   Google Scholar
• Japan Pediatric Society Vaccine Schedule [in Japanese]. 2012. 3–26–2013. Tokyo, Japan: The Japan Pediatric Society
   Google Scholar
• Vital Statistics for Japan 2008. Tokyo, Japan: Statistics Bureau, the Ministry of Internal Affairs and Communications. 2009
   Google Scholar
• Iwata S, Nakata S, Ukae S, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother 2013;9. [Epub ahead of print]
   Google Scholar
• Dennehy PH, Vesikari T, Matson DO, et al. Efficacy of the pentavalent rotavirus vaccine, RotaTeq(R) (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen). Hum Vaccin 2011;7:563-8
   PubMed Web of Science ®Google Scholar
• Boom JA, Tate JE, Sahni LC, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010;29:1133-5
   PubMed Web of Science ®Google Scholar
• Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125:e199-207
   PubMed Web of Science ®Google Scholar
• Ministry of Health Labor and Welfare. Diagnosis Procedure Combination 2010 [in Japanese]. 2010. Tokyo, Japan: The Ministry of Health Labor and Welfare
   Google Scholar
• Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375:1969-87
   PubMed Web of Science ®Google Scholar
• Kawai K, O'Brien MA, Goveia MG, et al. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine 2012;30:1244-54
   PubMed Web of Science ®Google Scholar
• Kawamura N. Economic burden derived from rotavirus enteritis on families of pediatric patients [abstract] Kawamura N. 41st Annual Meeting of the Japanese Society for Pediatric Infectious Diseases 2009. Fukui, Japan
   Google Scholar
• Kitahori Y, Inoue Y, Takebe H, et al. Serotyping of human group A rotaviruses in Nara Prefecture, Japan. Jpn J Infect Dis 2003;56:39-41
   Google Scholar
• Rotavirus and Vaccination. Nagoya, Japan: Nagoya City's official information site http://www.city.nagoya.jp/kenkofukushi/page/0000034344.html [in Japanese]. [Accessed on 26 Dec 2012]
   Google Scholar
• Asada N. Nagoya city announced the 50% financial support for rotavirus vaccination from October. Chunichi Shimbun, 2012. Nagoya, Japan
   Google Scholar
• Dennehy PH, Goveia MG, Dallas MJ, et al. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int J Infect Dis 2007;11(2 Suppl):S36-42
   Google Scholar
• Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. USA: Oxford University Press, 2008
   Google Scholar
• Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 2005;115:e600-14
   PubMed Web of Science ®Google Scholar
• Grange A, Bekker H, Noyes J, et al. Adequacy of health-related quality of life measures in children under 5 years old: systematic review. J Adv Nurs 2007;59:197-220
   PubMed Web of Science ®Google Scholar
• Happich M, von Lengerke T. Valuing the health state ‘tinnitus': differences between patients and the general public. Hear Res 2005;207:50-8
   PubMed Web of Science ®Google Scholar
• Ungar WJ. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? Pharmacoeconomics 2011;29:641-52
   PubMed Web of Science ®Google Scholar
• Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics 2007;25:713-26
   PubMed Web of Science ®Google Scholar
• Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ 2005;24:751-73
   PubMed Web of Science ®Google Scholar
• Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine 2012;30:3320-8
   PubMed Web of Science ®Google Scholar
• Van der Wielen M, Giaquinto C, Gothefors L, et al. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract 2010;11:22
   PubMed Web of Science ®Google Scholar